Smoking cessation: Progress, priorities, and prospectus

Journal of Consulting and Clinical Psychology

Volumn 70, Issue 3, 2002, Pages 494-509

  Niaura, Raymond ^a   Abrams, David B ^a  

^a MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NICOTINE GUM; NON PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HUMAN; INHALER; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; SEX DIFFERENCE; SMOKING CESSATION; TOBACCO DEPENDENCE;

HEALTH PROMOTION; HUMANS; SMOKING; SMOKING CESSATION;

EID: 0036279107     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.70.3.494     Document Type: Article

References (163)

1. Motivational characteristics of smokers at the worksite: A public health challenge
2. Smoking cessation at the workplace: Conceptual and practical considerations
3. Challenges and future directions for tailored communication research
4. Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: A combined stepped care and matching model
5. Costs of smoking: A focus on maternal, childhood, and other short-run costs
6. Cluster randomised controlled trial of expert system based on the transtheoretical ("stages of change") model for smoking prevention and cessation in schools
7. The health care costs of smoking
8. Changes in youth cigarette use and intentions following implementation of a tobacco control program: Findings from the Florida Youth Tobacco Survey
9. Monoamine oxidases and tobacco smoking
10. Monoamine oxidase A and B activities in heavy smokers
11. Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow-up
12. Nicotine inhaler and nicotine patch: A combination therapy for smoking cessation
13. Long-term follow-up results of a randomized drug abuse prevention trial in a white middle class population
14. Motivational consulting versus brief advice for smokers in general practice: A randomized trial
15. Genetic influence on smoking: A study of male twins
16. Cigarette smoking among adults - United States, 1992
17. Guidelines for school health programs to prevent tobacco use and addiction
18. Medical-care expenditures attributable to cigarette smoking - United States, 1993
19. Surveillance for smoking-attributable mortality and years of potential life lost, by state - United States, 1990
20. Cigarette smoking among adults - United States, 1994
21. Incidence of initiation of cigarette smoking - United States, 1965-1996
22. Selected cigarette smoking initiation and quitting behaviors among high school students
23. Cigarette smoking among adults - United States, 1997
24. State Medicaid coverage for tobacco dependence treatments - United States, 1998 and 2000
25. A genetic analysis of smoking behavior in family members of older adult males
26. Hutchison Smoking Prevention Project: A new gold standard in prevention science requires new transdisciplinary thinking
27. Brief motivational interviewing in a hospital setting for adolescent smoking: A preliminary study
28. Community Intervention Trial for Smoking Cessation (COMMIT): I. Cohort results from a four-year community intervention
29. Community Intervention Trial for Smoking Cessation (COMMIT): II. Changes in adult cigarette smoking prevalence
30. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation
31. Community-wide interventions for tobacco control
32. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization
33. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
34. Editorial: Uniting physicians against smoking: The need for a coordinated national strategy
35. Changing physicians' practices
36. Combined use of nicotine replacement products
37. Nicotine dependence versus smoking prevalence
38. Effects of community-wide education on cardiovascular disease risk factors: The Stanford Five-City Project
39. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease
40. Smoking status as the new vital sign: Effect on assessment and intervention in patients who smoke
41. Methods used to quit smoking in the United States: Do cessation programs help?
42. Changes in adult cigarette smoking prevalence after 5 years of community health education: The Stanford Five-City Project
43. Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase B (MAO B) inhibition
44. Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence
45. Smoking cessation interventions among hospitalized patients: What have we learned?
46. Genetic association studies in psychiatry: Recent history
47. Take heart: Results from the initial phase of a work-site wellness program
48. Cigarette smoking: Implications for psychiatric illness
49. Smoking cessation and the course of major depression: A follow-up study
50. Essential elements of school-based smoking prevention programs
51. Physicians counseling smokers. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions
52. Smoking
53. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler
54. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers
55. Mood management and nicotine gum in smoking treatment: A therapetic contact and placebo-controlled study
56. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
57. Sustained-release bupropion for pharmacolgic relapse prevention after smoking cessation: A randomized controlled trial
58. Genetic models for natural history of smoking: Evidence for a genetic influence on smoking persistence
59. Nicotine gum, 2 and 4 mg., for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program
60. Antidepressant pharmacotherapy helps some cigarette smokers more than others
61. Pharmacotherapy for smoking cessation: Unvalidated assumptions, anomalies, and suggestions for further research
62. An algorithm for smoking cessation
63. Combining behavioral therapy and pharmacotherapy for smoking cessation: An update
64. Dependence on and abuse of nicotine replacement medications: An update
65. American Psychiatric Association practice guideline for the treatment of patients with nicotine dependence
66. Recent advances in the pharmacotherapy of smoking
67. Nicotine patch therapy in 101 adolescent smokers: Efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels
68. A comparison of sustained-release bupropion and placebo for smoking cessation
69. A managed-care perspective on the AHCPR guideline
70. The Healthy Worker Project: A worksite intervention for weight control and smoking cessation
71. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
72. Predicting smoking cessation: Who will quit with and without the nicotine patch
73. Editorial: Beyond the tobacco settlement
74. Combined use of nicotine patch and gum in smoking cessation
75. A controlled trial to integrate smoking cessation advice into primary care practice: Doctors Helping Smokers, Round III
76. One size does not fit all: The case for trailoring print materials
77. Changes in adult cigarette smoking in the Minnesota Heart Health Program
78. Smoking and mental illness: A population-based prevalence study
79. Evidence suggesting the role of specific genetic factors in cigarette smoking
80. The smoking problem: A behavioral perspective
81. Behavioral research contributions and needs in cancer prevention and control: Tobacco use prevention and cessation
82. Smoking cessation: What have we learned over the past decade?
83. Telephone counseling for smoking cessation: Rationales and meta-analytic review of evidence
84. Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke
85. The tobacco settlement: An analysis of newspaper coverage of a national policy debate, 1997-98
86. Measuring physician readiness to change cancer screening: Preliminary results
87. Clinical interventions in tobacco control: A National Cancer Institute training program for physicians
88. Impact of the American Stop Smoking Intervention Study on cigarette comsumption
89. Office-based interventions to improve delivery of cancer prevention services by primary care physicians
90. Results from the first annual survey on addressing tobacco in managed care
91. Quantifying the burden of disease and injury attributable to ten major risk factors
92. Multicenter trial of fluoxetine as adjunct to behavioral smoking cessation treatment
93. Tobacco control activities of primary-care physicians in the Community Intervention Trial for Smoking Cessation: COMMIT Research Group
94. Relapse and maintenance issues for smoking cessation
95. Treating nicotine dependence in medical settings: A stepped-care model
96. Minimal-contact quit smoking strategies for medical settings
97. Guidance for commissioners on the cost effectiveness of smoking cessation interventions
98. A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs at the work-site: 1991-1993 update
99. A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effcts in rats
100. Smoking cessation in women: Special considerations
101. Sex differences in nicotine effects and self-administration: Review of human and animal evidence
102. Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women
103. Hutchinson Smoking Prevention Project: Long-term randomized trial in school-based tobacco use prevention - Results on smoking
104. Nicotine metabolism defect reduces smoking
105. Any further progress in smoking cessation treatment?
106. Nicotinic receptors in the brain: Links between molecular biology and behavior
107. Effectiveness of a minimal contact smoking cessation program for Dutch general practitioners: A randomized controlled trial
108. Introduction to the featured section: Genetic research on smoking
109. A randomized trial of nortriptyline for smoking cessation
110. Relationship between modifiable health risks and short-term health care charges
111. Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia Project)
112. Smoking cessation guidelines for health professionals
113. U.S. college students use of tobacco products: Results of a national survey
114. An evidence-based approach to interactive health communication: A challenge to medicine in the information age
115. Effectiveness of school-based programs as a component of a statewide tobacco control initiative - Oregon, 1999-2000
116. Helping smokers make decisions: The enhancement of brief intervention for general medical practice
117. Nicotinemecamylamine treatment for smoking cessation: The role of precessation therapy
118. A genetic association for cigarette smoking behavior
119. Using the hygiene visit to deliver a tobacco cessation program: Results of a randomized clinical trial
120. Smoking cessation treatment: Any progress?
121. The effect of bupropion on nicotine craving and withdrawal
122. Tobacco dependence treatments: Review and prospectus
123. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine polacrilex gum therapy
124. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy
125. Public health benefit of over-the-counter nicotine medications
126. Community stop-smoking contests in the COMMIT trial: Relationship of participation to costs
127. Smoking cessation in primary care clinics
128. Strike while the iron is hot: Can stepped-care treatments resurrect relapsing smokers?
129. Nicotine patch therapy in adolescent smokers
130. Aids to quitting tobacco use: How important are they outside controlled trials?
131. Work site-based cancer prevention: Primary results from the Working Well Trial
132. Randomized trial of brief family interventions for general populations: Adolescent substance use outcomes 4 years following baseline
133. Effects of thirty-four adolescent tobacco use cessation and prevention trials on regular users of tobacco products
134. A placebo-controlled double-blind combination trial of nicotine patch and spray
135. Randomised controlled trial of nasal nicotine spray in smoking cessation
136. Subgroups of smokers with different success rates after use of transdermal nicotine
137. Five hundred life saving interventions and their cost effectiveness
138. National patterns in the treatment of smokers by physicians
139. Distribution of smokers by stage in three representative samples
140. An expert system intervention for smoking cessation
141. Interactive versus noninteractive interventions and dose-response relationships for stage-matched smoking cessation programs in a managed care setting
142. A systems model of clinical preventive care: An analysis of factors influencing patient and physician
143. Cost effectiveness of smoking cessation therapies: Interpretation of the evidence and implications for coverage
144. Smoking out the incentives for tobacco control in managed care settings
145. The physician's role in health promotion revisited - A survey of primary care practioners
146. Increased levels of cigarette use among college students: A cause for national concern
147. The nicotine replacement paradox in smoking cessation: How does nicotine gum really work?
148. A randomised controlled trial of a 'buddy' system to improve success at giving up smoking in general practice
149. Gender differences in response to nicotine replacement therapy: Objective and subjective indices of tobacco withdrawal
150. Gender differences in smoking cessation
151. Telephone counseling for smoking cessation: Effects of single-session and multiple-session interventions